BridgeMD
New treatment option for Unilateral Spatial Neglect (USN)
Official title Rehabilitation Methods for Unilateral Spatial Neglect in Stroke Patients
ClinicalTrials.gov ID: NCT06802159
What this study is testing
- What it's testing
- Stroke remains one of the leading causes of mortality and disability worldwide. Between 30% and 40% of patients who have had an acute cerebral hemorrhage, develop unilateral spatial neglect syndrome (USN).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Normal cognitive development in accordance with age and educational level;
- diagnosis with codes I63, I61 (ICD);
- presence of unilateral spatial neglect syndrome in the neuropsychological status.
You likely can't join if
- presence of mental and somatic pathology of severe degree and in decompensation stage;
- the presence of gross oculomotor disorders;
- presence of a sensory visual defect of moderate to severe severity
The study team makes the final eligibility decision.
Where it's taking place
- Moscow, Moscow, Russia
- Moscow, Russia
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Moscow, Moscow, Russia; Moscow, Russia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.